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Abstract
Purpose Aim of this study was to evaluate the responsiveness of the Dutch version of the Achilles tendon Total Rupture 
Score (ATRS-NL).
Methods Patients (N = 47) completed the ATRS-NL at 3 and 6 months after Achilles tendon rupture (ATR). Additionally, 
they filled out the Euroqol-5D-5L (EQ-5D-5L) and Global Rating of Change Score (GRoC). Effect sizes (ES) and standard-
ized response means (SRM) were calculated. The anchor-based method for determining the minimally important change 
(MIC) was used. GRoC and improvement on the items mobility and usual activities on the EQ-5D-5L served as external 
criteria. The scores on these anchors were used to categorize patients’ physical functioning as improved or unchanged between 
3 and 6 months after ATR. Receiver operating curve (ROC) analysis was performed, with the calculation of the area under 
the ROC curve (AUC) and the estimation of MIC values using the optimal cut-off points.
Results There was a large change (ES: 1.58) and good responsiveness (SRM: 1.19) of the ATRS-NL between 3 and 6 months 
after ATR. Using ROC analysis, the MIC values ranged from 13.5 to 28.5 for reporting improvement on EQ-5D-5L mobility 
and GRoC, respectively. The AUC of improvement on mobility and improvement on GRoC were > 0.70.
Conclusion The ATRS-NL showed good responsiveness in ATR patients between 3 and 6 months after injury. Use of this 
questionnaire is recommended in clinical follow-up and longitudinal research of ATR patients. MIC values of 13.5 and 28.5 
are recommended to consider ATR patients as improved and greatly improved between 3 and 6 months after ATR.
Level of evidence II.
Keywords Achilles tendon rupture · PROM · Questionnaire · Epidemiology · ATRS · Dutch · Responsiveness · Minimally 
important change · Follow-up
Introduction
Patient-reported outcome measures (PROMs) provide the 
patient’s perception of the recovery and outcome of treat-
ment [1]. To be applicable and useful in research, PROMs 
must show adequate measurement properties [2]. Tradition-
ally, validity and reliability were considered the fundamental 
characteristics of a measurement instrument [3]; while these 
provide sufficient information on an instrument’s descriptive 
properties, responsiveness is required before it can be used 
as an outcome measure to assess change over time [4–6]. 
Responsiveness is defined as ‘the ability of an instrument 
to detect changes over time’ [7]. Without evidence that 
the PROM is sensitive to changes over time, usefulness in 
longitudinal research is insufficient, as meaningful effects 
go undetected [8]. PROMs are also increasingly used to 
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enhance clinical management and to evaluate the results of 
treatment over time [1, 9]. Given that the primary goal of 
medical treatment is to produce change, responsiveness is 
also an essential property for clinicians choosing a PROM 
for patient follow-up [6, 10].
Several PROMs are available to assess outcome in foot 
and ankle and Achilles tendon disorders [11, 12]. To assess 
the outcome after Achilles tendon rupture (ATR) specifi-
cally, only one tool exists that is considered valid and reli-
able: the Achilles tendon Total Rupture Score (ATRS) 
[13]. This 10-item questionnaire has been translated and 
shows sufficient validity and reliability in several languages 
[14–24], including Dutch (ATRS-NL) [25]. However, data 
on the responsiveness of the ATRS-NL are lacking.
Overall, there are two methods to assess the responsive-
ness of a PROM: a distribution-based and an anchor-based 
method. Besides the study regarding the development and 
validation of the ATRS [26], only three studies have assessed 
the responsiveness of a translation of the ATRS, determin-
ing effect size (ES) and relative efficiency using distribu-
tion-based approaches [17, 18, 27]. Distribution-based 
approaches assess change based on the statistical charac-
teristics of the sample. A limitation of distribution-based 
approaches is that they do not provide data on clinically 
relevant change [28–30]. Using anchor-based approaches, 
the smallest change in score that is considered a relevant 
change by either the patient or the clinician, the minimally 
important change (MIC), can be calculated [7]. These data 
facilitate the interpretation of change scores and increase 
the usability of PROMs [31]. To our knowledge, there are 
no data on the MIC of the ATRS questionnaire in any lan-
guage. The aim of this study was therefore to investigate the 
responsiveness of the ATRS-NL.
Materials and methods
Data for this study were collected from a study population 
of a multicentre prospective cohort study. The study proto-
col has been previously described [32]. All participants that 
participated in the 3-month (T1) and 6-month (T2) follow-
up measurements were included in the current study. This 
study was approved by the local Medical Ethical Commit-
tee (METc) of the University Medical Center Groningen 
(UMCG) (METc 2017/126). This study was locally approved 
(local feasibility) by the Medical Ethical Committees of the 
Martini Hospital Groningen (MHG) (MEC 2017–087) and 
Medical Center Leeuwarden (MCL) (COV 274(a)).
Participants
A multicentre prospective cohort study was performed at the 
UMCG, MHG and MCL in the Netherlands between July 
2017 and May 2019. Inclusion criteria for this study were 
patients aged 18 or older who were diagnosed and treated 
for an acute total ATR at UMCG, MHG, and/or MCL. Par-
ticipants were included within the first 3 months post-injury. 
Exclusion criteria were inability to read Dutch or cognitively 
understand the questionnaires. All participants were given 
written and oral information prior to granting informed 
consent.
A total of 50 participants were included in the multicentre 
prospective cohort study, three of whom were lost to follow-
up between T1 and T2. This study, therefore, included a total 
of 47 participants who had measurements at both T1 and T2.
Outcome measures
Dutch version of the Achilles tendon Total Rupture Score 
(ATRS‑NL)
The ATRS-NL is a disease-specific, self-administered 
PROM that can be used to measure outcome related to 
symptoms and physical activity after treatment in patients 
with an ATR [25, 26]. This PROM consists of 10 questions 
using an 11-point (0–10) Likert scale, with a maximum 
score (= maximum disability) of 100 points. A minimum 
score of 0 indicates no symptoms and full function/recovery. 
Five questions address symptoms and five questions address 
physical activity related to ATR [26]. This instrument is con-
sidered a valid and reliable method to evaluate outcome in 
ATR patients [25, 26].
Dutch version of the Euroqol‑5D‑5L (EQ‑5D‑5L)
The EQ-5D-5L is a commonly used generic questionnaire 
to measure health-related quality of life. It encompasses 
five subdivisions related to physical, mental, emotional and 
social functioning where, in the 5L-version, questions are 
administered on a 5-point Likert scale pertaining to the five 
levels/dimensions of severity: no problems (1), slight prob-
lems (2), moderate problems (3), severe problems (4) and 
extreme problems (5) [33].
Anchors
No gold-standard external criterion for improvement (after 
ATR) exists, therefore it is recommended to use multiple 
independent anchors [34–37]. Both global ratings and lon-
gitudinal disease-related measures of outcome are recom-
mended for determining meaningful clinical change [34]. 
This study, therefore, used three patient-reported anchors as 
external criteria: the Global rating of Change score (GRoC) 
and the EQ-5D-5L items mobility and usual activities.
The GRoC was constructed based on the meth-
ods of Jaeschke et al. [38]. It can quantify the degree in 
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patient-perceived improvement over a specified period of 
time [38]. Participants were asked to report the perceived 
change in symptoms and impairment regarding the injured 
Achilles tendon at 6 months compared to 3 months after 
ATR. The magnitude of this change was scored on a 5-point 
Likert scale ranging from ‘much more impairment’ (− 2), to 
‘more impairment’ (− 1) ‘about the same’ (0), ‘less impair-
ment’ (+ 1) and ‘much less impairment’ (+ 2).
Two other anchors were derived from the Dutch version 
of the EQ-5D-5L. Because the ATRS was developed and 
found valid to measure outcome related to symptoms and 
physical activity, this study used the EQ-5D-5L items related 
to mobility and usual activities. An evaluation of responsive-
ness of the English ATRS also used these subdivisions [27].
Study procedures
At T1 ATR patients were administered the ATRS-NL and 
the Dutch version of the EQ-5D-5L. Three months later (T2) 
participants were administered both these questionnaires for 
the second time in combination with the GRoC.
Data analysis
The scores on the GRoC scale were dichotomized. Partici-
pants who reported ‘much less impairment’ (+ 2) were cat-
egorized as improved. Similarly to other researchers, par-
ticipants reporting ‘less impairment’ (+ 1) were classified as 
equivalent to ‘about the same’ (0) for the MIC analysis [39] 
and categorized as unchanged. Participants reporting ‘more 
impairment’ (− 1) and ‘much more impairment’ (− 2) were 
excluded from the anchor-based MIC analysis.
The change in scores on the EQ-5D-5L subdivisions 
mobility and usual activities were also dichotomized. Partic-
ipants reporting an increase in at least one dimension (≥ 1) 
were considered improved and those reporting no increase 
in dimensions (0) were considered unchanged. Participants 
reporting a decrease in at least one dimension were excluded 
from the anchor-based MIC analysis.
For the ATRS-NL to be responsive it needs to demon-
strate a lack of floor and ceiling effects, meaning participants 
should not record the maximum or the minimum score for 
each time point. Floor and ceiling effects were present if 
more than 15% of respondents achieved the lowest or highest 
possible scores [30].
Statistical analysis
All statistical analyses were performed using IBM SPSS 
software, version 23.0 for Windows (IBM Corporation, 
Armonk, NY). A p value < 0.05 was considered statistically 
significant in all analyses. Descriptive statistics (mean and 
standard deviation (SD), median and interquartile range 
(IQR), and frequencies) were used for participant charac-
teristics and to display outcomes of the questionnaires. Both 
distribution-based and anchor-based methods were applied 
to assess responsiveness.
Distribution‑based approach
The effect sizes (ES) as described by Cohen et al. were cal-
culated [40, 41]. Using this method the difference between 
the mean ATRS-NL T2 and T1 scores, divided by the SD of 
T1 scores was calculated. A value of 0.2 represents a small 
change (one-fifth of the baseline SD), 0.5 a moderate change 
and > 0.8 a large change in score.
The standardized response mean (SRM) was calculated 
according to the method described by Liang et al. [42]. This 
measure compares the results of the ATRS-NL scores at T1 
and T2 and examines the magnitude of the change in scores. 
The SRM is the ratio of the mean change between T2 and T1 
to the SD of this mean change [29, 42]. SRM values < 0.5 are 
considered to indicate low responsiveness, 0.5–0.8 moderate 
and > 0.8 large responsiveness [43]. According to Norman 
et al. [44], a value of half the SD of the mean change in score 
was used as a conservative estimate of the MIC.
Anchor‑based approach
The diagnostic performance including calculation of MIC 
values of the ATRS-NL for detecting improvement was 
assessed by constructing receiver operating curves (ROC) 
[45] to evaluate the change in ATRS-NL scores as hav-
ing improved based on GRoC and the EQ-5D-5L subdivi-
sions mobility and usual activities. For all ROCs, the point 
on the curve nearest the upper-left corner was selected as 
the cut-off score for the MIC to minimize the sum of the 
percentage of patients being misclassified ((1 − sensitiv-
ity) + (1 − specificity)) [46, 47]. This point was determined 
by drawing a diagonal line from the upper-left corner of 
the ROC to the lower-right corner. The coordinate closest 
to this line or at which this line intersects the curve is con-
sidered to be the point closest to the upper-left corner [48] 
and, in this case, reflects the MIC of the ATRS-NL. The 
diagnostic performance of this MIC value was evaluated: 
sensitivity, specificity, and positive and negative predictive 
values (PPV/NPV) were calculated. Additionally, the per-
centage of patients misclassified as improved on the anchor 
using the MIC was calculated. Responsiveness was further 
assessed by determining the area under the ROC (AUC). 
AUC values > 0.5 were interpreted as the ATRS-NL having 
some discriminating ability concerning improvement in an 
anchor: 0.6–0.7 sufficient, 0.7–0.8 good, 0.8–0.9 very good 
and > 0.9 outstanding [49].
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Sample size
There is no general agreement on the appropriate sample 
size for PROM evaluations [10]. Previous studies that pro-
vided distribution-based responsiveness data of the English 
ATRS included 49 [17] and 64 [27] patients. The COSMIN 
initiative recommends a sample size of at least 30 and pref-
erably more than 50 participants for responsiveness evalua-




A total of 47 patients were available for follow-up at both 
3 months (T1) and 6 months (T2). Patient characteristics 
including primary treatment are presented in Table 1. In 
terms of complications, there were three re-ruptures, one 
deep vein thrombosis and two infections that occurred after 
primary treatment (surgical/non-surgical). One re-rupture 
occurred between T2 and T1 in a non-surgically treated 
patient, who was subsequently treated surgically.
Distribution‑based approach
Data on the ATRS-NL and ES and SRM values are pre-
sented in Table 2. As expected, the ATRS-NL did not dis-
play any floor or ceiling effects, as no participant achieved 
the minimum or maximum score at T1 or T2.
The ES (1.58) indicated a large change in ATRS-NL score 
between T2 and T1, and the SRM (1.19) a large responsive-
ness of the ATRS-NL for the entire study population. Using 
the criterion of half of the SD of the change in ATRS-NL, 
the estimated MIC is 10.
Anchor‑based approach
The scores on the anchors are presented in Table  3. 
For each anchor, two participants (4%) reported ‘more/
much more impairment’ on GRoC, decreased mobility 
on EQ-5D-5L or decreased usual activity functioning on 
EQ-5D-5L, and were excluded from the anchor-based MIC 
analyses.
Data on the ATRS-NL for patients categorized as 
improved and unchanged based on the GRoC and EQ-
5D-5L subdivisions mobility and usual activities are pre-
sented in Table 4.
MIC estimation for improvement
The results of the ROC analysis for determining MIC cut-
off using the three patient-reported anchors are presented 
in Table 5. The MIC ranged from 13.5 for improvement 
using EQ-5D-5L mobility to 28.5 using the GRoC. The 
AUC showed good (≥ 0.7) discriminating ability of the 
ATRS-NL in detecting improvement on the GRoC and the 
subdivision mobility of the EQ-5D-5L, and poor (0.49) 
discriminating ability for detecting improvement of the 
EQ-5D-5L subdivision usual activities. The results show 
that the calculated MIC scores misclassify less than 25% 
of all patients as improved.
Table 1  Baseline characteristics
*Presented as mean (SD) or count
Characteristic Participants* (N = 47)
Age (years) 41.6 (11.7)
Gender (male/female) 31/16
BMI (kg/m2) 25.4 (3.2)
Physically active (yes/no) 39/8
Surgical/non-surgical treatment 13/34
Table 2  Mean ATRS-NL scores 
at follow-up and distribution-
based statistics for entire sample 
(n = 47)
T1, mean (SD) 65.5 (15.4)
T2, mean (SD) 41.2 (21.8)
T1–T2, mean (SD) 24.4 (20.4)
ES 1.58
SRM 1.19
Table 3  Anchor outcomes
*Categories that together form the category unchanged
Anchor Dimension T1, n (%) T2, n (%) p value
GRoC − 2 N/A 0
− 1 2 (4%)
0* 2 (4%)
+ 1* 18 (38%)
+ 2 25 (53%)
EQ-5D-5L mobility Level 1 2 (4%) 26 (55%) < 0.0001
Level 2 22 (47%) 13 (27%)
Level 3 19 (40%) 8 (17%)
Level 4 2 (4%) 0
Level 5 2 (4%) 0
EQ-5D-5L usual activi-
ties
Level 1 10 (21%) 32 (68%) < 0.0001
Level 2 17 (36%) 11 (23%)
Level 3 19 (40%) 4 (9%)
Level 4 1 (2%) 0
Level 5 0 0
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Discussion
The most important finding of this study is that the ATRS-
NL is a responsive instrument capable of detecting rel-
evant change between 3 and 6 months after ATR. This 
has been the first study to provide MIC data on the ATRS 
questionnaire in any language. There was a large range of 
MIC values depending on the approach used and anchor 
applied. Use of this injury-specific PROM can be recom-
mended both for longitudinal research and for clinicians 
in the follow-up of Dutch ATR patients.
This study adheres to the requirements of the COSMIN 
checklist [10, 50]. In the absence of a single gold-standard 
external criterion multiple ones were used in a longitudi-
nal design, and as expected most participants evidenced 
improvement. The distribution-based approach showed 
the ATRS-NL is responsive in detecting improvement at 
a group level. The latter was performed in a sample of 47 
patients, which is considered adequate for PROM evalu-
ations, especially given that SRM/ES data is independent 
of sample size [41]. The MIC values provide evidence for 
the use of the ATRS-NL by clinicians and researchers in 
selecting the group of patients who are improving. These 
MIC values can be applied in individual analyses too, as 
it is argued that similar MIC values are found for groups 
and individuals, albeit with a higher degree of uncertainty 
at the individual level [31].
Good responsiveness of the ATRS-NL was determined 
with the distribution-based approach. As expected, there 
was a large change in scores for the entire study popula-
tion between 3 and 6 months after ATR, shown by the ES 
(1.58) and SRM (1.19) values. The few prior studies that 
also assessed the responsiveness of the ATRS used only 
distribution-based approaches and found similar large ES 
values (1.01 and 0.93) in the first 6 months after ATR [17, 
18].
With the anchor-based approach the ability of the ATRS-
NL to discriminate between patients who retrospectively 
report much less impairment (MIC: 28.5) and who prospec-
tively report improved mobility (MIC: 13.5) was confirmed. 
Because of the lack of a gold-standard anchor for improve-
ment after ATR, the MIC of the change in ATRS-NL scores 
was calculated using three patient-reported external criteria 
(anchors). There was a wide range in calculated MIC values 
with this approach, depending on which anchor was used to 
assess improvement. Overall, the ATRS-NL proved to be 
accurate in classifying patients as improved on GRoC and 
the EQ-5D-5L mobility subdivision (AUC > 0.7) and showed 
a low percentage (13% and 21%) of misclassifying patients 
as improved based on the optimal cut-off MIC. Neverthe-
less, the corresponding MIC values showed that relatively 
large changes in ATRS-NL scores are required to accurately 
classify patients as improved, whereas the distribution-based 
data showed that these large changes were occurring in this 
Table 4  ATRS-NL data by 
transition category on GRC 
and EQ-5D-5L subdivisions 
mobility and usual activities 
(n = 45)
Anchor Transition N T1, mean (SD) T2, mean (SD) T2–T1, mean (SD)
GRoC Improved 25 63.3 (14.2) 32.2 (18.1) − 32.0 (19.3)
Unchanged 20 68.5 (15.5) 50.8 (21.9) − 18.0 (17.6)
EQ-5D-5L mobility Improved 35 67.1 (14.0) 39.1 (21.3) − 28.3 (21.0)
Unchanged 10 58.5 (20.0) 44.6 (23.4) − 13.9 (14.0)
EQ-5D-5L usual activities Improved 29 65.5 (15.8) 40.8 (21.6) − 25.1 (22.3)
Unchanged 16 65.0 (15.9) 38.9 (22.0) − 26.1 (16.2)
Table 5  Responsiveness measures and MIC values for improvement on the specific anchors (n = 45)
a Minimally important change
b Area under the ROC curve
c Positive predictive value
d Negative predictive value




PPVc (%) NPVd (%) Misclassifica-
tion percentage 
(%)
GRoC − 28.5 0.71 (0.56; 0.87) 60 80 79 62 21
EQ-5D-5L mobility − 13.5 0.72 (0.56; 0.88) 77 60 87 44 13
EQ-5D-5L usual activities − 25.5 0.49 (0.31; 0.66) 55 69 76 46 24
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study population. The latter can be explained by the follow-
up period in the recovery phase, where improvement can be 
expected. This period of follow-up resulted in the relatively 
large sample who were considered improved or unchanged 
and were thus available for anchor-based MIC analyses 
(n = 45). It is recommended that future studies also assess 
the responsiveness of the ATRS-NL in a more long-term 
follow-up, where relatively smaller changes in improvement 
can be expected.
It has been proposed that the observed MIC is smallest 
for the anchor that shows the highest correlation with the 
scale used in the study [51]. For the ATRS-NL, this con-
cerned determining improvement in mobility on EQ-5D-5L 
(− 13.5). This can be explained by the original purpose of 
developing the ATRS: to reflect the restrictions caused by 
symptoms during various physical activities after ATR [26]. 
The ATRS-NL was not responsive to improvement when 
using the EQ-5D-5L item usual activities. By using this 
anchor a large MIC was found (− 25.5), but a small AUC 
(0.49) and low sensitivity and specificity (55 and 69%, 
respectively). This finding contrasts with those of Kear-
ney et al. [27], who found similar correlations between the 
English ATRS and the EQ-5D-3L items usual activities and 
mobility. This is thought to be the result of using the 3-point 
Likert scale EQ-5D; in the present study the updated 5-point 
scale was used, allowing for more sensitive reporting in cat-
egorizing patients as having improved [52].
The study population consisted of both non-surgical and 
surgically treated patients, which we believe does not influ-
ence the results, given that short-term ATRS scores are not 
significantly different between treatment groups [53]. Nev-
ertheless, only 10% of studies comparing ATR treatment 
methods use the ATRS as an outcome measure in comparing 
short-term results [53]. On the other hand, all studies com-
paring surgical and non-surgical treatment report re-rupture 
rates [53]. A limitation of this outcome measure is that it 
does not adequately represent the patient function. Given the 
discriminating ability of the ATRS-NL in detecting improve-
ment, we suggest this practice be re-evaluated and additional 
well-designed trials and observational studies are performed.
Up to 50 region-specific PROMs for foot and ankle dis-
orders are available and have been studied for their clini-
metric properties [11, 12]. Similar to the studies on the 
ATRS questionnaire, research tends to focus on the validity 
and reliability of these PROMs; data on responsiveness is 
mostly lacking [11]. To our knowledge, of these 50 PROMs 
only evidence for the responsiveness of the foot and ankle 
ability measure (FAAM), Manchester-Oxford foot question-
naire (MOXFX), foot and ankle outcome score (FAOS) and 
Oxford ankle foot questionnaire for children exists (OxAFQ) 
[11, 12, 54]. Additionally, all of the Dutch foot and ankle 
PROMs show either no data on responsiveness or poor 
responsiveness [55], which may explain why only 6% of 
Dutch surgeons treating ATRs use PROMs in monitoring 
treatment progress after ATR [56]. It is, therefore, recom-
mended that researchers and clinicians use the ATRS(-NL) 
as opposed to other foot and ankle PROMs in the follow-
up of ATR patients. The lack of responsiveness reporting 
contrasts with the recommendations made by the COSMIN 
expert panel, who state it to be an essential measurement 
property [10]. Hence it is recommended that in future 
research on the development and validation of foot and ankle 
PROMs responsiveness also be analyzed, preferably using 
distribution-based and anchor-based methods.
This study has several strengths. First of all, both dis-
tribution and anchor-based methods were used to evaluate 
responsiveness. Because no single valid gold-standard exter-
nal criterion exists and the validity of retrospective global 
rating of change is debated [57], this study used three dif-
ferent patient-reported anchors, both retrospective and pro-
spective, as recommended by the COSMIN initiative [2, 
10]. Nevertheless, no single individual external criterion is 
clearly valid, which is a limitation of this study. Data were 
gathered prospectively during a multicentre cohort study, 
increasing the generalizability of results. Also, this study 
focused on a follow-up period that is considered relevant 
for clinicians and researchers alike (3 and 6 months post-
ATR). This is when clinicians see patients for follow-up after 
primary treatment and early into rehabilitation (3 months), 
and before return to normal function (6 months). However, 
the focus on an identical follow-up period in the recovery 
phase is another limitation of this study. In the absence of 
complications most patients will have improved, limiting the 
sample of participants reporting deterioration of symptoms 
and physical activity following ATR. The design and follow-
up period of this study (3 and 6 months after ATR) resulted 
in the anticipated large improvement in ATRS-NL scores. 
Data on the ability of the ATRS-NL to detect regression are 
therefore lacking. Additionally, whether these data can be 
extrapolated to changes seen more in the long term—at the 
time of return to sport/usual function—might be debatable 
and would require assessing responsiveness using different, 
sport-specific anchors. Responsiveness at a later stage in 
ATR recovery should be assessed in future research, espe-
cially given that deficits persist for years [58] and return to 
sports is a tedious process [59].
This study provides evidence to support the use of the 
ATRS(-NL) by clinicians and researchers in the follow-up 
of ATR patients. The ATRS-NL is valid, reliable, easy to 
administer and score and—as shown by the current study—
responsive to change in the clinical follow-up period (3 and 
6 months) after ATR. In addition, MIC values have been 
derived from this study. De Vet et al. have already acknowl-
edged that no universal MIC value for a single PROM exists 
[47]. It is, therefore, advised that a single value be set, but 
with a small range to allow for variation in interpretation 
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[47, 60]. It is recommended researchers and clinicians use 
a MIC of 13.5 as the minimum change in score to consider 
patients as having improved, as the results show this value 
to accurately detect prospective improvement on EQ-5D-5L 
mobility. To identify the subgroup of patients who show the 
best improvement between 3 and 6 months after ATR, we 
suggest a MIC of 28.5, as this is the cut-off value for detect-
ing patients who retrospectively report ‘much less impair-
ment’ on GRoC.
Conclusion
The position of the ATRS-NL as a primary outcome meas-
ure in longitudinal research and clinical practice is con-
firmed: it is a valuable tool in investigating the efficacy and 
effectiveness of an intervention. MIC values of 13.5 and 28.5 
are recommended to consider patients as having improved 
and greatly improved between 3 and 6 months after ATR. 
Overall, we believe this study is an important step in value-
based healthcare by contributing towards more valid, reli-
able and responsive PROMs.
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